Diabetes Clinical Trials in Boston

Showing 301-320 of 534 trials

Extended Follow-Up After Islet Transplantation in T1D

NCT01369082

The purpose of this study is to provide patients who have received at least one islet transplant as a previous participant in a Clinical Islet Transplantation Consortium (CIT) clinical trial with maintenance immunosuppressive medications and to collect information about the safety of the medications and islet function.

Type 1 Diabetes (T1D)Islet Transplantation

National Institute of Allergy and Infectious Diseases (NIAID)75 participantsStarted May 2011

San Francisco, California, United States • Miami, Florida, United States • Atlanta, Georgia, United States +5 more locations

COMPLETEDPhase 2< 1 mile

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

NCT00495469

This is a dose-ranging study to evaluate the efficacy, safety and tolerability of a range of doses of GSK189075 (an SGLT2 inhibitor) compared to placebo, administered over 12 weeks in treatment-naive subjects with type 2 diabetes mellitus

Diabetes Mellitus, Type 2

GlaxoSmithKline250 participantsStarted Aug 2007

Mesa, Arizona, United States • Artesia, California, United States • Buena Park, California, United States +154 more locations

Extended Follow-Up After Islet Transplantation in T1D

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

Diabetes Trials in Other Cities

The Summer Camp Study 2: Blood Glucose Control With a Bi-Hormonal Endocrine Pancreas

Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon

Physical Health in Midlife: Influences of Adversity and Relationships Over Time

UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation

Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI

Evaluation of Fats on Postprandial Glucose Control

Effect of Dietary Fat on Glycemic Control in Type 1 Diabetes

Glycemic Index - Variability Among Individuals

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

Thiazolidinedione Intervention With Vitamin D Evaluation

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes

A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin

Other Conditions in Boston